Correlation Between NLS Pharmaceutics and Reviva Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NLS Pharmaceutics AG and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on NLS Pharmaceutics and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Reviva Pharmaceuticals.

Diversification Opportunities for NLS Pharmaceutics and Reviva Pharmaceuticals

-0.65

Correlation Coefficient

NLS Pharmaceutics  Reviva Pharmaceuticals

Excellent diversification

The 3 months correlation between NLS and Reviva is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Reviva Pharmaceuticals go up and down completely randomly.

Pair Corralation between NLS Pharmaceutics and Reviva Pharmaceuticals

Given the investment horizon of 90 days NLS Pharmaceutics AG is expected to under-perform the Reviva Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, NLS Pharmaceutics AG is 3.38 times less risky than Reviva Pharmaceuticals. The stock trades about -0.23 of its potential returns per unit of risk. The Reviva Pharmaceuticals Holdings is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  11.00  in Reviva Pharmaceuticals Holdings on September 14, 2024 and sell it today you would earn a total of  23.96  from holding Reviva Pharmaceuticals Holdings or generate 217.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

NLS Pharmaceutics AG  vs.  Reviva Pharmaceuticals Holding

NLS Pharmaceutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NLS Pharmaceutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Reviva Pharmaceuticals

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain technical indicators, Reviva Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NLS Pharmaceutics and Reviva Pharmaceuticals

The main advantage of trading using opposite NLS Pharmaceutics and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.

The idea behind NLS Pharmaceutics AG and Reviva Pharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.